Sauveur Jeanty

Title: Sauveur Jeanty: Innovator in Microfluidic Kidney-on-Chip Technology

Introduction

Sauveur Jeanty is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of microfluidics, particularly in the development of kidney-on-chip technologies. With a total of 3 patents to his name, Jeanty's work is paving the way for advancements in drug testing and personalized medicine.

Latest Patents

One of Jeanty's latest patents is focused on the microfluidic proximal tubule kidney-on-chip. This invention relates to microfluidic devices, methods, and systems designed to replicate human kidney functions. The kidney-on-chip technology includes various components such as the Proximal Tubule-Kidney-Chip, Glomerulus (Kidney)-Chip, and Collecting Duct (Kidney)-Chip. These devices are instrumental in drug testing, including drug transport and renal clearance. They also facilitate the determination of drug-drug interactions and their effects on renal transporter functions. Importantly, these innovations are applicable in pre-clinical and clinical drug development for treating kidney diseases and advancing personalized medicine.

Career Highlights

Jeanty is currently associated with Emulate, Inc., a company known for its cutting-edge work in organ-on-chip technology. His role at Emulate allows him to further explore and develop innovative solutions that address critical challenges in healthcare.

Collaborations

Throughout his career, Jeanty has collaborated with notable colleagues, including Kyung-Jin Jang and Hyoungshin Park. These collaborations have contributed to the advancement of research and development in the field of microfluidics.

Conclusion

Sauveur Jeanty's contributions to microfluidic kidney-on-chip technology are significant and impactful. His work not only enhances drug testing methodologies but also plays a crucial role in the future of personalized medicine.